NDAQ:ARTL - Post Discussion
Post by
whytestocks on Jul 10, 2023 8:00pm
Artelo Biosciences CEO to Participate in the Benzinga All Ac
News; $ARTL Artelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11SOLANA BEACH, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announ...
ARTL - Artelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11
Be the first to comment on this post